Shannon Thyme Klinger is Chief Legal Officer of Moderna, Inc.. Currently has a direct ownership of 20,446 shares of MRNA, which is worth approximately $666,539. The most recent transaction as insider was on Mar 01, 2024, when has been sold 233 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.4K
12.63% 3M change
158.42% 12M change
Total Value Held $666,539

Shannon Thyme Klinger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2024
BUY
Exercise of conversion of derivative security
-
233 Added 2.58%
8,790 Common Stock
Feb 29 2024
SELL
Open market or private sale
$63,361 $94.57 p/Share
670 Reduced 7.26%
8,557 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
1,315 Added 12.47%
9,227 Common Stock
Dec 08 2023
SELL
Open market or private sale
$44,527 $79.09 p/Share
563 Reduced 6.64%
7,912 Common Stock
Dec 07 2023
BUY
Exercise of conversion of derivative security
-
1,139 Added 11.85%
8,475 Common Stock
Dec 04 2023
SELL
Open market or private sale
$8,803 $79.31 p/Share
111 Reduced 1.49%
7,336 Common Stock
Dec 01 2023
BUY
Exercise of conversion of derivative security
-
232 Added 3.02%
7,447 Common Stock
Sep 08 2023
SELL
Open market or private sale
$59,721 $107.22 p/Share
557 Reduced 7.17%
7,215 Common Stock
Sep 07 2023
BUY
Exercise of conversion of derivative security
-
1,138 Added 12.77%
7,772 Common Stock
Sep 05 2023
SELL
Open market or private sale
$12,815 $111.44 p/Share
115 Reduced 1.7%
6,634 Common Stock
Sep 01 2023
BUY
Exercise of conversion of derivative security
-
233 Added 3.34%
6,749 Common Stock
Jun 08 2023
SELL
Open market or private sale
$70,110 $124.09 p/Share
565 Reduced 7.98%
6,516 Common Stock
Jun 07 2023
BUY
Exercise of conversion of derivative security
-
1,139 Added 13.86%
7,081 Common Stock
Jun 02 2023
SELL
Open market or private sale
$14,335 $130.32 p/Share
110 Reduced 1.82%
5,942 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
232 Added 3.69%
6,052 Common Stock
Mar 08 2023
SELL
Open market or private sale
$79,387 $141.51 p/Share
561 Reduced 8.79%
5,820 Common Stock
Mar 07 2023
BUY
Exercise of conversion of derivative security
-
1,138 Added 15.13%
6,381 Common Stock
Mar 02 2023
SELL
Open market or private sale
$62,621 $136.43 p/Share
459 Reduced 8.05%
5,243 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
-
930 Added 14.02%
5,702 Common Stock
Dec 08 2022
SELL
Open market or private sale
$87,783 $179.15 p/Share
490 Reduced 9.31%
4,772 Common Stock
Dec 07 2022
BUY
Exercise of conversion of derivative security
-
1,139 Added 17.79%
5,262 Common Stock
Sep 08 2022
SELL
Open market or private sale
$65,696 $137.44 p/Share
478 Reduced 10.8%
3,949 Common Stock
Sep 07 2022
BUY
Exercise of conversion of derivative security
-
1,138 Added 20.45%
4,427 Common Stock
Jun 08 2022
SELL
Open market or private sale
$187,372 $148.12 p/Share
1,265 Reduced 27.78%
3,289 Common Stock
Jun 07 2022
BUY
Exercise of conversion of derivative security
$637,560 $140.0 p/Share
4,554 Added 50.0%
4,554 Common Stock

Also insider at

RFL
Rafael Holdings, Inc. Real Estate
STK

Shannon Thyme Klinger

Chief Legal Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA